2017 American Transplant Congress
Risk Factors for Hospital Readmission with Urinary Tract Infections (UTIs) Following Kidney Transplantation (KT).
UTIs are common causes of hospital readmissions after KT. Our objective is to determine predictors of hospital readmissions for UTI within 1 year after a…2017 American Transplant Congress
Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.
BackgroundThe Internet has extensive online resources for kidney transplantation recipients. However, it is unclear if these materials are comprehensible for kidney transplant patients. Nearly, one-half…2017 American Transplant Congress
Outcomes for Plasma Cell Rich Rejection in Pediatric Kidney Transplant Patients.
Medical University of South Carolina, Charleston
Introduction and Objective:Plasma cell rich rejection (PCR) has historically been associated with poor outcomes, but there has been minimal data published to date on pediatric…2017 American Transplant Congress
Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.
With a range of frequencies reported in several small studies, true incidence of de novo donor-specific human leukocyte antigen (HLA) antibodies (dnDSA) is unknown. As…2017 American Transplant Congress
The Molecular Phenotypes of Rejection in Kidney Transplant Biopsies.
University of Alberta, Edmonton, AB, Canada
In a microarray analysis of 1208 kidney transplant indication biopsies, each biopsy was assigned molecular scores for seven phenotypes related to various aspects of TCMR,…2017 American Transplant Congress
Retrospective Analysis of Multiple Hemodialysis Access Modalities.
1Tampa General Hospital, Tampa, FL; 2University of South Florida, Tampa, FL
The use of native arteriovenous fistulas (AVF) for hemodialysis (HD) is the gold standard, however, for many patients, this is not an option. We hypothesize…2017 American Transplant Congress
Defining a BKV Cutt-Off and Profile for Early Detection of BKV Associated Nephropathy.
BK polyomavirus-associated nephropathy (BKPyVAN) represents a challenge to transplant centers. Prevention using early detection of BKPy viremia (BKPyV) and immunosuppression(IS) reduction is the best current…2017 American Transplant Congress
Immunosuppressive Therapy and Acute Rejection in Combined Heart and Kidney Transplantation.
University of Louisville, Louisville
Background. This study evaluated the management of immunosuppressive therapy and the incidence of acute heart rejection within 1 year from concomitant heart-kidney transplantation (cHTKx) compared…2017 American Transplant Congress
Knowledge of Chronic Kidney Disease Among Liver Transplant Patients.
Background: A significant proportion of liver transplant (LT) pts develop advanced chronic kidney disease (CKD) that negatively impacts mortality and morbidity. Our aim was to…2016 American Transplant Congress
Effect of Isolated Intraperitoneal Sirolimus Treatment on the Kidneys of C57BL/6 Mice.
Sirolimus, a mammalian target of rapamycin inhibitor, is widely used in transplantation. However, the mechanism by which sirolimus induces adverse effects such as proteinuria and…
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 101
- Next Page »